UK markets close in 5 hours 44 minutes

Infinity Pharmaceuticals, Inc. (INFI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4300+0.0200 (+1.42%)
At close: 04:00PM EST
1.4500 +0.02 (+1.40%)
After hours: 05:40PM EST
Full screen
Loading interactive chart…
  • Business Wire

    Infinity to Present at 40th Annual J.P. Morgan Healthcare Conference

    CAMBRIDGE, Mass., January 06, 2022--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced that Adelene Perkins, Chief Executive Officer, will give a corporate presentation at 7:30am ET on January 13, 2022 at the 40th annual J.P. Morgan Healthcare Conference, taking place virtually.

  • Business Wire

    Infinity Pharmaceuticals Outlines Eganelisib Clinical Development Strategy and Provides 2022 Guidance

    CAMBRIDGE, Mass., January 05, 2022--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today provided an update on eganelisib clinical development plans and 2022 guidance.

  • Business Wire

    Infinity Pharmaceuticals Added to the NASDAQ Biotechnology Index

    CAMBRIDGE, Mass., December 14, 2021--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI), effective as of market open on Monday, December 20, 2021.